Metraipolis › archive › dc_4499c033a659

Real-world glycemic control, exploratory cardiorenal indicators, and safety of polyethylene glycol loxenatide versus semaglutide in type 2 diabetes patients:… — Europe PMC PMID:41953701

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41953701
DOI
10.3389/fendo.2026.1756581
License (as archived)
solo-consultazione
Archived
2026-11-04T00:14:10.109Z
SHA-256 of the archived text
e53251dae6e84470bf291538ecd0f07fdbd266248307d6ba9e091bc8b4604c7a
Stable URL of this page
https://metraipolis.com/documento/dc_4499c033a659

How to cite

Real-world glycemic control, exploratory cardiorenal indicators, and safety of polyethylene glycol loxenatide versus semaglutide in type 2 diabetes patients:… — Europe PMC PMID:41953701 — Europe PMC (en), https://europepmc.org/article/MED/41953701 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4499c033a659 (Metraipolis archive dc_4499c033a659, sha256 e53251dae6e84470bf291538ecd0f07fdbd266248307d6ba9e091bc8b4604c7a)
BibTeX
@misc{dc4499c033a659,
  title = {Real-world glycemic control, exploratory cardiorenal indicators, and safety of polyethylene glycol loxenatide versus semaglutide in type 2 diabetes patients:… — Europe PMC PMID:41953701},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41953701},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4499c033a659; sha256 e53251dae6e84470bf291538ecd0f07fdbd266248307d6ba9e091bc8b4604c7a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41953701. Agents can read the archived copy with the MCP tool read_document.